526 related articles for article (PubMed ID: 6233365)
1. Interleukin 2 enhancement of lymphokine secretion by T lymphocytes: analysis of established clones and primary limiting dilution microcultures.
Kelso A; MacDonald HR; Smith KA; Cerottini JC; Brunner KT
J Immunol; 1984 Jun; 132(6):2932-8. PubMed ID: 6233365
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid inhibition of lymphokine secretion by alloreactive T lymphocyte clones.
Kelso A; Munck A
J Immunol; 1984 Aug; 133(2):784-91. PubMed ID: 6203981
[TBL] [Abstract][Full Text] [Related]
3. Secretion of interleukin 2, macrophage-activating factor, interferon, and colony-stimulating factor by alloreactive T lymphocyte clones.
Kelso A; Glasebrook AL
J Immunol; 1984 Jun; 132(6):2924-31. PubMed ID: 6202766
[TBL] [Abstract][Full Text] [Related]
4. Positively selected Lyt-2+ and Lyt-2- mouse T lymphocytes are comparable, after Con A stimulation, in release of IL 2 and of lymphokines acting on B cells, macrophages, and mast cells, but differ in interferon production.
Guerne PA; Piguet PF; Vassalli P
J Immunol; 1983 May; 130(5):2225-30. PubMed ID: 6187845
[TBL] [Abstract][Full Text] [Related]
5. Retrovirus-mediated immunosuppression. II. FeLV-UV alters in vitro murine T lymphocyte behavior by reversibly impairing lymphokine secretion.
Orosz CG; Zinn NE; Olsen RG; Mathes LE
J Immunol; 1985 Jul; 135(1):583-90. PubMed ID: 2987350
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of lymphokine production by murine T-lymphocyte clones.
MacDonald HR; Glasebrook AL; Kelso A; Zubler RH
Ann Immunol (Paris); 1982; 133D(2):171-8. PubMed ID: 6819809
[TBL] [Abstract][Full Text] [Related]
7. Reversibility of lymphokine-induced NK-like activity in virus-specific cytotoxic T-lymphocyte clones.
Ronchese F; Collavo D; Zanovello P; Cerundolo V; Biasi G
Immunology; 1985 Feb; 54(2):265-74. PubMed ID: 2578429
[TBL] [Abstract][Full Text] [Related]
8. Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities.
Kelso A; Glasebrook AL; Kanagawa O; Brunner KT
J Immunol; 1982 Aug; 129(2):550-6. PubMed ID: 7045227
[TBL] [Abstract][Full Text] [Related]
9. Lymphokine-mediated induction of cytolytic activity in a T cell hybridoma.
Kanagawa O; Chiller JM
J Immunol; 1985 Jan; 134(1):397-403. PubMed ID: 3917280
[TBL] [Abstract][Full Text] [Related]
10. Effects of monoclonal antibodies directed against murine T lymphocyte cell surface antigens on lymphokine production by cloned T lymphocytes reactive with class I MHC or Mls alloantigens.
Lancki DW; Prystowsky MB; Vogel SN; Beller DI; Dialynas DP; Fitch FW
J Immunol; 1984 Oct; 133(4):2051-7. PubMed ID: 6236262
[TBL] [Abstract][Full Text] [Related]
11. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
Sensi M; Orosz CG; Bach FH
J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
[TBL] [Abstract][Full Text] [Related]
12. Production of interleukin 2, interleukin 3, and interferon by mouse T lymphocyte clones of Lyt-2+ and -2- phenotype.
Guerne PA; Piguet PF; Vassalli P
J Immunol; 1984 Apr; 132(4):1869-71. PubMed ID: 6199414
[TBL] [Abstract][Full Text] [Related]
13. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
[TBL] [Abstract][Full Text] [Related]
14. Frequency analysis of lymphokine-secreting CD4+ and CD8+ T cells activated in a graft-versus-host reaction.
Kelso A
J Immunol; 1990 Oct; 145(7):2167-76. PubMed ID: 1975827
[TBL] [Abstract][Full Text] [Related]
15. The functional association of Lyt antigens with lymphokine production.
Hollander N; Shepshalovich J
Immunology; 1985 Jan; 54(1):25-33. PubMed ID: 2579021
[TBL] [Abstract][Full Text] [Related]
16. Precursor frequency analysis of lymphokine-secreting alloreactive T lymphocytes. Dissociation of subsets producing interleukin 2, macrophage-activating factor, and granulocyte-macrophage colony-stimulating factor on the basis of Lyt-2 phenotype.
Kelso A; Macdonald HR
J Exp Med; 1982 Nov; 156(5):1366-79. PubMed ID: 6752327
[TBL] [Abstract][Full Text] [Related]
17. Distinction between antigen receptor and IL 2 receptor triggering events in the activation of alloreactive T cell clones with calcium ionophore and phorbol ester.
Albert F; Hua C; Truneh A; Pierres M; Schmitt-Verhulst AM
J Immunol; 1985 Jun; 134(6):3649-55. PubMed ID: 3921610
[TBL] [Abstract][Full Text] [Related]
18. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 2 is both necessary and sufficient for the growth and differentiation of lectin-stimulated cytolytic T lymphocyte precursors.
Erard F; Corthesy P; Nabholz M; Lowenthal JW; Zaech P; Plaetinck G; MacDonald HR
J Immunol; 1985 Mar; 134(3):1644-52. PubMed ID: 3871453
[TBL] [Abstract][Full Text] [Related]
20. Clonal heterogeneity in colony stimulating factor production by murine T lymphocytes.
Kelso A; Metcalf D
J Cell Physiol; 1985 Apr; 123(1):101-10. PubMed ID: 3156138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
